FactorPad
Build a Better Process

Stock Risk Measures for Coherus Biosciences Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 55 for CHRS below.

/ factorpad.com / stocks / f55zkw.html


An ad-free and cookie-free webpage by FactorPad


CHRS Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Coherus Biosciences Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how CHRS stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f55zkw.html


CHRS stock risk
COHERUS BIOSCIENCES INC stock beta
CHRS risk report
CHRS f55zkw
CHRS risk analysis
CHRS volatility
COHERUS BIOSCIENCES INC credit risk
CHRS liquidity risk
CHRS leverage
CHRS valuation
CHRS systematic risk
CHRS specific risk
COHERUS BIOSCIENCES INC volatility
CHRS analysis
CHRS financial ratio

This is a new resource, spread the word, tell a friend